Serbia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.7 (0.60 - 0.81) 2019 Modelled IHME
0.7 (0.60 - 0.79) 2018 Modelled IHME
0.7 (0.60 - 0.80) 2017 Modelled IHME
0.71 (0.61 - 0.81) 2016 Modelled IHME
0.73 (0.62 - 0.84) 2015 Modelled IHME
0.75 (0.64 - 0.85) 2014 Modelled IHME
0.76 (0.65 - 0.86) 2013 Modelled IHME
0.78 (0.67 - 0.88) 2012 Modelled IHME
0.8 (0.67 - 0.91) 2011 Modelled IHME
0.81 (0.68 - 0.93) 2010 Modelled IHME
0.83 (0.70 - 0.94) 2009 Modelled IHME
0.84 (0.71 - 0.97) 2008 Modelled IHME
0.85 (0.72 - 0.98) 2007 Modelled IHME
0.87 (0.74 - 1) 2006 Modelled IHME
0.88 (0.74 - 1.02) 2005 Modelled IHME
0.89 (0.76 - 1.02) 2004 Modelled IHME
0.9 (0.77 - 1.03) 2003 Modelled IHME
0.91 (0.78 - 1.04) 2002 Modelled IHME
0.92 (0.78 - 1.05) 2001 Modelled IHME
0.93 (0.79 - 1.06) 2000 Modelled IHME
0.94 (0.80 - 1.07) 1999 Modelled IHME
0.95 (0.81 - 1.08) 1998 Modelled IHME
0.96 (0.81 - 1.10) 1997 Modelled IHME
0.97 (0.82 - 1.11) 1996 Modelled IHME
0.97 (0.81 - 1.12) 1995 Modelled IHME
0.97 (0.81 - 1.12) 1994 Modelled IHME
0.97 (0.81 - 1.11) 1993 Modelled IHME
0.96 (0.81 - 1.10) 1992 Modelled IHME
0.95 (0.80 - 1.10) 1991 Modelled IHME
0.94 (0.78 - 1.08) 1990 Modelled IHME
0.98 (0.70 - 1.33) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.06 (0.04 - 0.08) 2019 Modelled IHME
0.07 (0.05 - 0.09) 2018 Modelled IHME
0.07 (0.05 - 0.09) 2017 Modelled IHME
0.06 (0.05 - 0.08) 2016 Modelled IHME
0.06 (0.04 - 0.08) 2015 Modelled IHME
0.06 (0.04 - 0.08) 2014 Modelled IHME
0.06 (0.04 - 0.07) 2013 Modelled IHME
0.06 (0.04 - 0.07) 2012 Modelled IHME
0.06 (0.04 - 0.07) 2011 Modelled IHME
0.06 (0.04 - 0.07) 2010 Modelled IHME
0.06 (0.05 - 0.08) 2009 Modelled IHME
0.08 (0.06 - 0.11) 2008 Modelled IHME
0.11 (0.08 - 0.15) 2007 Modelled IHME
0.15 (0.11 - 0.20) 2006 Modelled IHME
0.19 (0.14 - 0.25) 2005 Modelled IHME
0.25 (0.18 - 0.33) 2004 Modelled IHME
0.34 (0.25 - 0.44) 2003 Modelled IHME
0.44 (0.32 - 0.57) 2002 Modelled IHME
0.52 (0.38 - 0.67) 2001 Modelled IHME
0.57 (0.41 - 0.74) 2000 Modelled IHME
0.58 (0.42 - 0.76) 1999 Modelled IHME
0.6 (0.43 - 0.78) 1998 Modelled IHME
0.61 (0.44 - 0.80) 1997 Modelled IHME
0.61 (0.44 - 0.82) 1996 Modelled IHME
0.61 (0.44 - 0.83) 1995 Modelled IHME
0.61 (0.44 - 0.82) 1994 Modelled IHME
0.61 (0.43 - 0.80) 1993 Modelled IHME
0.6 (0.42 - 0.80) 1992 Modelled IHME
0.59 (0.41 - 0.79) 1991 Modelled IHME
0.57 (0.39 - 0.76) 1990 Modelled IHME
0.11 (0.06 - 0.17) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
88,547 (73,331 - 101,813) 1990 Modelled IHME
91,616 (76,408 - 105,271) 1991 Modelled IHME
93,478 (78,329 - 107,261) 1992 Modelled IHME
94,368 (79,271 - 108,302) 1993 Modelled IHME
95,323 (79,944 - 109,727) 1994 Modelled IHME
95,494 (80,009 - 110,298) 1995 Modelled IHME
95,084 (80,118 - 109,485) 1996 Modelled IHME
92,116 (77,765 - 105,362) 1997 Modelled IHME
88,421 (74,970 - 100,723) 1998 Modelled IHME
88,572 (75,312 - 100,667) 1999 Modelled IHME
89,057 (75,595 - 101,742) 2000 Modelled IHME
87,178 (74,143 - 99,138) 2001 Modelled IHME
85,566 (72,822 - 97,783) 2002 Modelled IHME
84,403 (71,968 - 96,610) 2003 Modelled IHME
82,829 (70,592 - 95,446) 2004 Modelled IHME
81,171 (68,608 - 94,566) 2005 Modelled IHME
79,665 (67,663 - 91,953) 2006 Modelled IHME
78,038 (65,954 - 89,536) 2007 Modelled IHME
76,294 (64,454 - 87,664) 2008 Modelled IHME
74,612 (63,221 - 85,290) 2009 Modelled IHME
73,026 (61,480 - 83,586) 2010 Modelled IHME
71,575 (60,419 - 81,432) 2011 Modelled IHME
70,135 (59,748 - 79,410) 2012 Modelled IHME
68,401 (58,220 - 77,257) 2013 Modelled IHME
66,615 (56,716 - 75,894) 2014 Modelled IHME
65,029 (55,275 - 74,580) 2015 Modelled IHME
63,124 (54,166 - 71,448) 2016 Modelled IHME
61,839 (52,966 - 70,438) 2017 Modelled IHME
61,548 (52,738 - 69,461) 2018 Modelled IHME
61,343 (52,161 - 70,456) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
4.64 (3.31 - 6.32) 2019 Modelled IHME
4.56 (3.29 - 6.16) 2018 Modelled IHME
4.52 (3.39 - 5.99) 2017 Modelled IHME
4.62 (3.60 - 5.89) 2016 Modelled IHME
4.97 (3.90 - 6.38) 2015 Modelled IHME
5.35 (4.19 - 6.81) 2014 Modelled IHME
5.82 (4.59 - 7.36) 2013 Modelled IHME
6.36 (5.01 - 7.97) 2012 Modelled IHME
6.83 (5.40 - 8.50) 2011 Modelled IHME
7.15 (5.70 - 8.82) 2010 Modelled IHME
7.41 (5.93 - 9.10) 2009 Modelled IHME
7.59 (6.07 - 9.33) 2008 Modelled IHME
7.57 (6.05 - 9.21) 2007 Modelled IHME
7.62 (6.12 - 9.32) 2006 Modelled IHME
7.65 (6.16 - 9.38) 2005 Modelled IHME
7.54 (6.07 - 9.20) 2004 Modelled IHME
7.43 (5.94 - 9.04) 2003 Modelled IHME
7.32 (5.85 - 8.95) 2002 Modelled IHME
7.34 (5.89 - 8.94) 2001 Modelled IHME
7.38 (5.88 - 9.04) 2000 Modelled IHME
7.31 (5.84 - 8.98) 1999 Modelled IHME
7.44 (5.96 - 9.14) 1998 Modelled IHME
7.68 (6.11 - 9.55) 1997 Modelled IHME
7.33 (5.82 - 9.06) 1996 Modelled IHME
7.14 (5.62 - 8.81) 1995 Modelled IHME
6.95 (5.27 - 8.82) 1994 Modelled IHME
6.77 (4.95 - 8.83) 1993 Modelled IHME
6.56 (4.74 - 8.52) 1992 Modelled IHME
6.44 (4.79 - 8.29) 1991 Modelled IHME
6.54 (4.95 - 8.30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
406 (289 - 553) 2019 Modelled IHME
401 (289 - 541) 2018 Modelled IHME
399 (299 - 528) 2017 Modelled IHME
409 (319 - 522) 2016 Modelled IHME
441 (346 - 567) 2015 Modelled IHME
476 (373 - 606) 2014 Modelled IHME
521 (411 - 658) 2013 Modelled IHME
571 (450 - 715) 2012 Modelled IHME
614 (485 - 763) 2011 Modelled IHME
643 (513 - 794) 2010 Modelled IHME
669 (535 - 822) 2009 Modelled IHME
689 (551 - 847) 2008 Modelled IHME
692 (553 - 842) 2007 Modelled IHME
701 (563 - 857) 2006 Modelled IHME
708 (570 - 867) 2005 Modelled IHME
702 (565 - 857) 2004 Modelled IHME
697 (557 - 848) 2003 Modelled IHME
688 (550 - 840) 2002 Modelled IHME
695 (558 - 846) 2001 Modelled IHME
706 (563 - 866) 2000 Modelled IHME
689 (550 - 846) 1999 Modelled IHME
692 (554 - 850) 1998 Modelled IHME
736 (586 - 915) 1997 Modelled IHME
720 (572 - 889) 1996 Modelled IHME
702 (553 - 867) 1995 Modelled IHME
683 (518 - 867) 1994 Modelled IHME
660 (483 - 861) 1993 Modelled IHME
637 (461 - 829) 1992 Modelled IHME
619 (461 - 797) 1991 Modelled IHME
614 (465 - 780) 1990 Modelled IHME
304 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
18 (12 - 25) 2019 Modelled IHME
18 (12 - 25) 2018 Modelled IHME
18 (12 - 25) 2017 Modelled IHME
18 (12 - 25) 2016 Modelled IHME
18 (13 - 26) 2015 Modelled IHME
19 (13 - 26) 2014 Modelled IHME
19 (14 - 27) 2013 Modelled IHME
20 (14 - 28) 2012 Modelled IHME
20 (14 - 28) 2011 Modelled IHME
21 (15 - 29) 2010 Modelled IHME
21 (15 - 29) 2009 Modelled IHME
21 (15 - 29) 2008 Modelled IHME
21 (15 - 29) 2007 Modelled IHME
21 (15 - 29) 2006 Modelled IHME
21 (15 - 29) 2005 Modelled IHME
21 (15 - 29) 2004 Modelled IHME
22 (15 - 30) 2003 Modelled IHME
22 (15 - 30) 2002 Modelled IHME
22 (15 - 30) 2001 Modelled IHME
22 (15 - 31) 2000 Modelled IHME
22 (15 - 31) 1999 Modelled IHME
22 (15 - 31) 1998 Modelled IHME
22 (16 - 31) 1997 Modelled IHME
23 (16 - 31) 1996 Modelled IHME
23 (16 - 31) 1995 Modelled IHME
23 (16 - 32) 1994 Modelled IHME
23 (16 - 32) 1993 Modelled IHME
23 (16 - 32) 1992 Modelled IHME
23 (16 - 32) 1991 Modelled IHME
23 (16 - 32) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
98 2005 Survey/reported WHO/UNICEF
98 2004 Survey/reported WHO/UNICEF
99 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
91 2018 Survey/reported WHO/UNICEF
93 2017 Survey/reported WHO/UNICEF
91 2016 Survey/reported WHO/UNICEF
94 2015 Survey/reported WHO/UNICEF
92 2014 Survey/reported WHO/UNICEF
91 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
94 2011 Survey/reported WHO/UNICEF
89 2010 Survey/reported WHO/UNICEF
93 2009 Survey/reported WHO/UNICEF
93 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
93 2006 Survey/reported WHO/UNICEF
65 2005 Survey/reported WHO/UNICEF
89 2004 Survey/reported WHO/UNICEF
94 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
4 (2.60 - 6) 2010 Survey/reported EMCDDA, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2006
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.11 (0.90 - 1.37) 2019 Modelled IHME
1.1 (0.90 - 1.36) 2018 Modelled IHME
1.1 (0.89 - 1.35) 2017 Modelled IHME
1.09 (0.89 - 1.33) 2016 Modelled IHME
1.09 (0.89 - 1.32) 2015 Modelled IHME
1.09 (0.89 - 1.32) 2014 Modelled IHME
1.1 (0.90 - 1.34) 2013 Modelled IHME
1.11 (0.90 - 1.36) 2012 Modelled IHME
1.12 (0.90 - 1.38) 2011 Modelled IHME
1.13 (0.90 - 1.40) 2010 Modelled IHME
1.12 (0.90 - 1.38) 2009 Modelled IHME
1.12 (0.90 - 1.37) 2008 Modelled IHME
1.11 (0.89 - 1.36) 2007 Modelled IHME
1.1 (0.89 - 1.34) 2006 Modelled IHME
1.1 (0.88 - 1.34) 2005 Modelled IHME
1.1 (0.88 - 1.33) 2004 Modelled IHME
1.09 (0.88 - 1.33) 2003 Modelled IHME
1.09 (0.88 - 1.33) 2002 Modelled IHME
1.09 (0.88 - 1.33) 2001 Modelled IHME
1.09 (0.88 - 1.33) 2000 Modelled IHME
1.09 (0.88 - 1.32) 1999 Modelled IHME
1.08 (0.87 - 1.31) 1998 Modelled IHME
1.07 (0.86 - 1.30) 1997 Modelled IHME
1.06 (0.85 - 1.29) 1996 Modelled IHME
1.05 (0.85 - 1.29) 1995 Modelled IHME
1.05 (0.84 - 1.28) 1994 Modelled IHME
1.04 (0.84 - 1.28) 1993 Modelled IHME
1.04 (0.84 - 1.27) 1992 Modelled IHME
1.04 (0.84 - 1.27) 1991 Modelled IHME
1.03 (0.84 - 1.27) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
25.9 (22.10 - 29.70) 2014 Modelled Degenhardt L et al, 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
97,165 (78,655 - 119,516) 1990 Modelled IHME
99,559 (80,403 - 122,277) 1991 Modelled IHME
101,015 (81,556 - 123,775) 1992 Modelled IHME
101,769 (81,927 - 124,526) 1993 Modelled IHME
102,899 (82,892 - 125,650) 1994 Modelled IHME
103,445 (83,293 - 126,585) 1995 Modelled IHME
103,986 (83,662 - 126,565) 1996 Modelled IHME
102,438 (82,364 - 124,362) 1997 Modelled IHME
100,311 (80,916 - 121,914) 1998 Modelled IHME
102,438 (82,430 - 124,281) 1999 Modelled IHME
104,521 (83,798 - 127,168) 2000 Modelled IHME
103,467 (83,504 - 125,794) 2001 Modelled IHME
102,736 (82,628 - 124,951) 2002 Modelled IHME
102,582 (82,670 - 124,505) 2003 Modelled IHME
101,987 (82,006 - 123,977) 2004 Modelled IHME
101,359 (81,567 - 123,755) 2005 Modelled IHME
101,228 (81,672 - 123,603) 2006 Modelled IHME
101,316 (81,540 - 124,075) 2007 Modelled IHME
101,381 (81,613 - 124,675) 2008 Modelled IHME
101,419 (81,199 - 125,046) 2009 Modelled IHME
101,260 (80,953 - 125,980) 2010 Modelled IHME
100,772 (80,701 - 124,291) 2011 Modelled IHME
99,930 (80,848 - 122,517) 2012 Modelled IHME
98,562 (80,184 - 120,247) 2013 Modelled IHME
97,273 (79,465 - 117,777) 2014 Modelled IHME
96,686 (78,783 - 117,144) 2015 Modelled IHME
96,695 (79,157 - 117,903) 2016 Modelled IHME
96,802 (78,568 - 119,416) 2017 Modelled IHME
96,819 (78,916 - 119,264) 2018 Modelled IHME
96,863 (78,940 - 119,998) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
6.57 (4.66 - 8.85) 2019 Modelled IHME
6.5 (4.78 - 8.63) 2018 Modelled IHME
6.39 (4.85 - 8.25) 2017 Modelled IHME
6.24 (4.92 - 7.70) 2016 Modelled IHME
6.21 (4.88 - 7.71) 2015 Modelled IHME
6.22 (4.89 - 7.74) 2014 Modelled IHME
6.16 (4.81 - 7.66) 2013 Modelled IHME
6.13 (4.85 - 7.65) 2012 Modelled IHME
6.17 (4.85 - 7.68) 2011 Modelled IHME
6.28 (4.92 - 7.79) 2010 Modelled IHME
6.49 (5.10 - 8.01) 2009 Modelled IHME
6.61 (5.22 - 8.21) 2008 Modelled IHME
6.58 (5.22 - 8.13) 2007 Modelled IHME
6.61 (5.27 - 8.17) 2006 Modelled IHME
6.6 (5.27 - 8.21) 2005 Modelled IHME
6.46 (5.15 - 7.98) 2004 Modelled IHME
6.31 (5.04 - 7.83) 2003 Modelled IHME
6.18 (4.91 - 7.72) 2002 Modelled IHME
6.19 (4.87 - 7.66) 2001 Modelled IHME
6.12 (4.83 - 7.64) 2000 Modelled IHME
6.06 (4.78 - 7.50) 1999 Modelled IHME
6.12 (4.77 - 7.63) 1998 Modelled IHME
6.23 (4.85 - 7.90) 1997 Modelled IHME
5.91 (4.62 - 7.43) 1996 Modelled IHME
5.72 (4.49 - 7.20) 1995 Modelled IHME
5.53 (4.23 - 7.20) 1994 Modelled IHME
5.36 (3.94 - 7.06) 1993 Modelled IHME
5.17 (3.76 - 6.85) 1992 Modelled IHME
5.06 (3.72 - 6.51) 1991 Modelled IHME
5.13 (3.87 - 6.57) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
575 (407 - 774) 2019 Modelled IHME
571 (420 - 758) 2018 Modelled IHME
564 (428 - 728) 2017 Modelled IHME
553 (436 - 682) 2016 Modelled IHME
552 (434 - 685) 2015 Modelled IHME
554 (435 - 689) 2014 Modelled IHME
551 (430 - 686) 2013 Modelled IHME
551 (435 - 687) 2012 Modelled IHME
554 (436 - 690) 2011 Modelled IHME
565 (442 - 700) 2010 Modelled IHME
586 (461 - 724) 2009 Modelled IHME
601 (474 - 745) 2008 Modelled IHME
602 (477 - 744) 2007 Modelled IHME
608 (485 - 752) 2006 Modelled IHME
610 (487 - 759) 2005 Modelled IHME
601 (479 - 743) 2004 Modelled IHME
591 (472 - 734) 2003 Modelled IHME
580 (461 - 725) 2002 Modelled IHME
586 (461 - 725) 2001 Modelled IHME
586 (462 - 731) 2000 Modelled IHME
571 (450 - 706) 1999 Modelled IHME
569 (443 - 709) 1998 Modelled IHME
597 (465 - 757) 1997 Modelled IHME
580 (454 - 729) 1996 Modelled IHME
562 (442 - 708) 1995 Modelled IHME
543 (416 - 707) 1994 Modelled IHME
523 (384 - 689) 1993 Modelled IHME
503 (365 - 666) 1992 Modelled IHME
486 (357 - 625) 1991 Modelled IHME
482 (364 - 617) 1990 Modelled IHME
551 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
35 (25 - 44) 2019 Modelled IHME
35 (26 - 44) 2018 Modelled IHME
35 (26 - 44) 2017 Modelled IHME
35 (25 - 44) 2016 Modelled IHME
34 (25 - 44) 2015 Modelled IHME
34 (25 - 44) 2014 Modelled IHME
34 (25 - 44) 2013 Modelled IHME
34 (25 - 43) 2012 Modelled IHME
34 (24 - 43) 2011 Modelled IHME
34 (24 - 43) 2010 Modelled IHME
34 (24 - 43) 2009 Modelled IHME
34 (24 - 43) 2008 Modelled IHME
34 (25 - 43) 2007 Modelled IHME
34 (25 - 43) 2006 Modelled IHME
34 (25 - 43) 2005 Modelled IHME
33 (24 - 43) 2004 Modelled IHME
33 (24 - 43) 2003 Modelled IHME
33 (24 - 42) 2002 Modelled IHME
33 (24 - 42) 2001 Modelled IHME
32 (24 - 42) 2000 Modelled IHME
33 (24 - 42) 1999 Modelled IHME
32 (23 - 42) 1998 Modelled IHME
32 (23 - 42) 1997 Modelled IHME
32 (23 - 42) 1996 Modelled IHME
32 (24 - 42) 1995 Modelled IHME
32 (24 - 42) 1994 Modelled IHME
32 (23 - 42) 1993 Modelled IHME
32 (23 - 42) 1992 Modelled IHME
32 (23 - 41) 1991 Modelled IHME
32 (23 - 42) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
4 (2.60 - 6) 2010 Survey/reported EMCDDA, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2006
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
406
2019
(289 - 553)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
575
2019
(407 - 774)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
99 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines